封面
市場調查報告書
商品編碼
1606411

熱療癌症治療市場,按設備類型、治療類型、應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Hyperthermia Cancer Treatment Market, By Device Type, By Treatment Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年熱療癌症治療市場規模為1.8921億美元,2024年至2032年複合年成長率為6.20%。

熱療癌症治療市場-市場動態

全球癌症盛行率的不斷上升預計將推動市場需求。

全球癌症發生率呈上升趨勢,每年報告新診斷數以百萬計。這種不斷升級的趨勢凸顯了更有效和多樣化的治療替代方案的必要性,例如熱療等先進療法。美國癌症協會預計,2023年,美國將新增癌症病例1,958,310例,癌症相關死亡人數將達609,820例。此外,熱療技術的進步和臨床研究的增加可能會帶來市場擴張的重大機會。然而,高成本和有限的可及性可能會阻礙這種成長。

熱療癌症治療市場 - 關鍵見解

根據我們的研究分析師分享的分析,預計全球市場在預測期內(2024-2032 年)每年將以 6.20% 左右的複合年成長率成長

根據設備類型細分,預計微波熱療設備將在 2023 年顯示最大的市場佔有率

根據應用細分,乳癌是 2023 年的領先類型

根據最終用戶細分,醫院是 2023 年的領先類型

按地區分類,北美是 2023 年的主要收入來源

熱療癌症治療市場-細分分析:

全球熱療癌症治療市場根據設備類型、治療類型、應用、最終用戶和地區進行細分。

根據設備類型,市場分為三類:微波熱療設備、超音波熱療設備、紅外線熱療設備和短波熱療設備。微波熱療儀在市場上處於領先地位。這些設備透過微波能產生熱量來發揮作用,專門針對和消除癌細胞,通常是透過提高腫瘤組織的溫度。

根據治療類型,市場分為兩個部分:局部熱療、區域熱療和全身熱療。隨著人們對熱療作為可行的治療替代方案的理解和接受程度不斷提高,預計局部、區域和全身熱療市場將經歷相當大的進步和創新。

根據應用,市場分為兩個部分:乳癌、肝癌、軟組織肉瘤、頭頸部腫瘤和攝護腺癌。乳癌是市場擴張的主要驅動力。熱療透過升高腫瘤組織的溫度來增強放射治療和化學治療的療效,是乳癌患者重要的輔助治療。

根據最終用戶,市場分為三類:醫院、診所、研究所和癌症中心。醫院板塊引領市場。熱療癌症治療市場在醫院中變得越來越重要,這種先進療法越來越被認為是癌症治療方案的重要組成部分。

熱療癌症治療市場 - 地理洞察

從地理來看,該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。由於先進的醫療設施和對研發的高度重視,預計北美將主導市場的成長。北美擁有世界上一些最先進的醫療機構,配備了尖端的醫療技術和基礎設施。這使得熱療治療得以有效實施。根據醫療產業統計,到2022年底,美國醫療保健支出將達4.5兆美元。美國目前擁有世界上最大的整體醫療保健支出。根據美國最新的醫療保健資料和報告,該國2021年的總體支出將為4.3兆美元,即GDP的18.5%。北美擁有數家處於癌症研究前沿的著名研究機構和大學。由於人們對熱療療法的認知不斷提高,歐洲成為市場成長的第二大地區。

熱療癌症治療市場-競爭格局:

熱療癌症治療市場的特點是有各種各樣的關鍵參與者和組織,他們在其發展中發揮重要作用。許多製藥公司正在進行旨在提高熱療與化療或免疫療法相結合的療效的研究。與設備製造商的合作普遍用於完善治療方案。成功滲透各個市場並保證其產品的可及性的公司將擁有競爭優勢。這涉及解決與成本相關的挑戰並確保不同地區的產品可用性。隨著對尖端癌症療法的需求持續成長,競爭格局預計將發生轉變,成功的實體將因其適應和創新能力而不斷湧現。

最新進展:

Pyrexar Medical 宣布與 Clinitech Co. Ltd 建立新的分銷聯盟,這將有助於在古巴、西印度群島、巴拿馬和委內瑞拉引入 Pyrexar 的熱療技術。

攝氏42有限公司是腫瘤學應用熱療系統的著名生產商,已與總部位於杜拜的Lootah集團建立了全面、長期的策略合作夥伴關係。

目錄

第1章:熱療癌症治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 按設備類型分類的熱療癌症治療市場片段
    • 按治療類型分類的熱療癌症治療市場片段
    • 熱療癌症治療市場片段(按應用)
    • 最終用戶的熱療癌症治療市場片段
    • 按國家/地區分類的熱療癌症治療市場片段
    • 按地區分類的熱療癌症治療市場片段
  • 競爭洞察

第 3 章:熱療癌症治療主要市場趨勢

  • 熱療癌症治療市場促進因素
    • 市場促進因素的影響分析
  • 熱療癌症治療市場限制
    • 市場限制影響分析
  • 熱療癌症治療市場機會
  • 熱療癌症治療市場未來趨勢

第 4 章:熱療癌症治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:熱療癌症治療市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章:熱療癌症治療市場格局

  • 熱療癌症治療市場佔有率分析,2023 年
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章:熱療癌症治療市場 - 按設備類型

  • 概述
    • 按設備類型分類的細分市場佔有率分析
    • 微波熱療儀
    • 超音波熱療儀
    • 紅外線熱療儀
    • 短波熱療儀

第 8 章:熱療癌症治療市場 - 依治療類型

  • 概述
    • 按治療類型分類的細分市場佔有率分析
    • 局部熱療
    • 局部熱療
    • 全身熱療

第 9 章:熱療癌症治療市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 乳癌
    • 肝癌
    • 軟組織肉瘤
    • 頭頸腫瘤
    • 攝護腺癌

第 10 章:熱療癌症治療市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 研究所
    • 癌症中心

第 11 章:熱療癌症治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美熱療癌症治療主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模和預測(按設備類型)
    • 北美市場規模和預測(按治療類型)
    • 北美市場規模和預測(按應用)
    • 北美市場規模和預測(按最終用戶)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲熱療癌症治療主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模和預測(按設備類型)
    • 歐洲市場規模和預測(按治療類型)
    • 歐洲市場規模和預測(按應用)
    • 歐洲市場規模和預測(按最終用戶)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區熱療癌症治療主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 亞太地區市場規模和預測(按設備類型)
    • 亞太地區市場規模與預測(按治療類型)
    • 亞太地區市場規模與預測(按應用)
    • 亞太地區市場規模和預測(按最終用戶)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲熱療癌症治療主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模和預測(按設備類型)
    • 拉丁美洲市場規模與預測(按治療類型)
    • 拉丁美洲市場規模與預測(按應用)
    • 拉丁美洲市場規模和預測(按最終用戶)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 熱療癌症治療中東和非洲主要製造商
    • 中東和非洲市場規模及預測(按國家)
    • 中東和非洲市場規模及預測(按設備類型)
    • 中東和非洲市場規模及預測(按治療類型)
    • 中東和非洲市場規模及預測(按應用)
    • 中東和非洲市場規模和預測(按最終用戶)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第12章:主要供應商分析-熱療癌症治療產業

  • 競爭儀表板
  • 公司簡介
    • Andromedic Srl
    • Oncotherm Kft
    • YAMAMOTO VINITA CO., LTD
    • Alba Hyperthermia System
    • Sensius, MagForce AG
    • Celsius42 GmbH
    • Pyrexar Medical
    • Nanoprobes
    • Novavida
    • Hydrosun GmbH
    • Chongqing Haifu Medical Technology Co., Ltd.
    • RanD
    • Gamida
    • Others

第 13 章:360 度分析師視角

第 14 章:附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4181

REPORT HIGHLIGHT

Hyperthermia Cancer Treatment Market size was valued at USD 189.21 Million in 2023, expanding at a CAGR of 6.20% from 2024 to 2032.

Hyperthermia is a therapeutic approach that involves elevating body tissue temperatures to as high as 113 °F, aiming to damage and eliminate cancer cells while minimizing harm to surrounding healthy tissue. This method, often referred to as thermal therapy, thermal ablation, or thermotherapy, is utilized to enhance the efficacy of other cancer treatments, such as radiation therapy or chemotherapy. In certain instances, the intense heat can completely eradicate cancer cells; however, it may also adversely affect normal cells and tissues.

Hyperthermia Cancer Treatment Market- Market Dynamics

The increasing prevalence of cancer worldwide is expected to propel market demand.

The worldwide incidence of cancer is on the rise, with millions of new diagnoses reported annually. This escalating trend highlights the necessity for more effective and varied treatment alternatives, such as advanced therapies like hyperthermia. The American Cancer Society projects that in 2023, there will be 1,958,310 new cancer cases and 609,820 cancer-related deaths in the United States. Additionally, advancements in hyperthermia technology and an increase in clinical research may present significant opportunities for market expansion. Nevertheless, high costs and limited accessibility could hinder this growth.

Hyperthermia Cancer Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.20% over the forecast period (2024-2032)

Based on Device Type segmentation, Microwave Hyperthermia Device was predicted to show maximum market share in the year 2023

Based on Application segmentation, Breast Cancer was the leading type in 2023

Based on End-User segmentation, the hospital was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Hyperthermia Cancer Treatment Market- Segmentation Analysis:

The Global Hyperthermia Cancer Treatment Market is segmented based on Device Type, Treatment Type, Application, End-User, and Region.

The market is segmented into three categories according to Device Type: Microwave Hyperthermia Device, Ultrasound Hyperthermia Device, Infrared Hyperthermia Device, and Short-wave Hyperthermia Device. The Microwave Hyperthermia Device holds a leading position in the market. These devices function by producing heat through microwave energy, which is specifically aimed at targeting and eliminating cancer cells, generally by increasing the temperature of tumor tissues.

The market is classified into two segments according to Treatment Type: Local Hyperthermia, Regional Hyperthermia, and Whole Body Hyperthermia. As the understanding and acceptance of hyperthermia as a viable treatment alternative grow, it is anticipated that the market for local, regional, and whole-body hyperthermia therapies will experience considerable progress and innovation.

The market is classified into two segments according to application: Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Head and Neck Tumors, and Prostate Cancer. Breast Cancer is the primary driver of market expansion. Hyperthermia therapy entails elevating the temperature of tumor tissues to enhance the efficacy of radiation and chemotherapy, thereby serving as a significant supplementary treatment for patients with breast cancer.

The market is segmented into three categories according to the end-user: Hospitals, Clinics, Research Institutes, and Cancer Centers. The hospital sector leads the market. The Hyperthermia Cancer Treatment Market is gaining significant importance within hospitals, where this advanced therapy is increasingly recognized as an essential element of cancer treatment protocols.

Hyperthermia Cancer Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, due to Advanced Healthcare facilities and a strong focus on research and development. North America is home to some of the most advanced healthcare facilities in the world, equipped with cutting-edge medical technology and infrastructure. This enables the effective implementation of hyperthermia treatment. According to healthcare industry statistics, at the end of 2022, the US will spend USD 4.5 trillion on healthcare. The United States currently has the greatest overall healthcare spending in the world. According to the most recent healthcare in the United States data and reports, the country's overall spending in 2021 will be USD 4.3 trillion, or 18.5% of GDP. North America boasts several prominent research institutions and universities that are at the forefront of cancer research. Europe holds the second largest region for market growth, due to rising awareness about Hyperthermia therapy.

Hyperthermia Cancer Treatment Market- Competitive Landscape:

The hyperthermia cancer treatment market is characterized by a diverse array of key players and organizations that play a significant role in its advancement. Numerous pharmaceutical companies are engaged in research aimed at improving the effectiveness of hyperthermia when combined with chemotherapy or immunotherapy. Partnerships with device manufacturers are prevalent to refine treatment protocols. Firms that successfully penetrate various markets and guarantee the accessibility of their products will hold a competitive advantage. This involves tackling cost-related challenges and ensuring product availability across different regions. As the demand for cutting-edge cancer therapies continues to rise, the competitive landscape is expected to transform, with successful entities emerging based on their capacity to adapt and innovate.

Recent Developments:

Pyrexar Medical has declared a new distribution alliance with Clinitech Co. Ltd., which will facilitate the introduction of Pyrexar's hyperthermia technologies in Cuba, the West Indies, Panama, and Venezuela.

Celsius42 GmbH, a prominent producer of hyperthermia systems for oncology applications, has established a comprehensive, long-term strategic partnership with the Lootah Group based in Dubai.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Andromedic S.r.l.
  • Oncotherm Kft
  • YAMAMOTO VINITA CO., LTD
  • Alba Hyperthermia System
  • Sensius, MagForce AG
  • Celsius42 GmbH
  • Pyrexar Medical
  • Nanoprobes
  • Novavida
  • Hydrosun GmbH
  • Chongqing Haifu Medical Technology Co., Ltd.
  • RanD
  • Gamida
  • Others

GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET, BY DEVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Microwave Hyperthermia Device
  • Ultrasound Hyperthermia Device
  • Infrared Hyperthermia Device
  • Short-wave Hyperthermia Device

GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Local Hyperthermia
  • Regional Hyperthermia
  • Whole Body Hyperthermia

GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Breast Cancer
  • Liver Cancer
  • Soft Tissue Sarcoma
  • Head & Neck Tumor
  • Prostate Cancer

GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Research Institutes
  • Cancer Centers

GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hyperthermia Cancer Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hyperthermia Cancer Treatment Market Snippet by Device Type
    • 2.1.2. Hyperthermia Cancer Treatment Market Snippet by Treatment Type
    • 2.1.3. Hyperthermia Cancer Treatment Market Snippet by Application
    • 2.1.4. Hyperthermia Cancer Treatment Market Snippet by End-User
    • 2.1.5. Hyperthermia Cancer Treatment Market Snippet by Country
    • 2.1.6. Hyperthermia Cancer Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Hyperthermia Cancer Treatment Key Market Trends

  • 3.1. Hyperthermia Cancer Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hyperthermia Cancer Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hyperthermia Cancer Treatment Market Opportunities
  • 3.4. Hyperthermia Cancer Treatment Market Future Trends

4. Hyperthermia Cancer Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hyperthermia Cancer Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hyperthermia Cancer Treatment Market Landscape

  • 6.1. Hyperthermia Cancer Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hyperthermia Cancer Treatment Market - By Device Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Device Type, 2023 & 2032 (%)
    • 7.1.2. Microwave Hyperthermia Device
    • 7.1.3. Ultrasound Hyperthermia Device
    • 7.1.4. Infrared Hyperthermia Device
    • 7.1.5. Short-wave Hyperthermia Device

8. Hyperthermia Cancer Treatment Market - By Treatment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Type, 2023 & 2032 (%)
    • 8.1.2. Local Hyperthermia
    • 8.1.3. Regional Hyperthermia
    • 8.1.4. Whole Body Hyperthermia

9. Hyperthermia Cancer Treatment Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Breast Cancer
    • 9.1.3. Liver Cancer
    • 9.1.4. Soft Tissue Sarcoma
    • 9.1.5. Head & Neck Tumor
    • 9.1.6. Prostate Cancer

10. Hyperthermia Cancer Treatment Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Research Institutes
    • 10.1.5. Cancer Centers

11. Hyperthermia Cancer Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Hyperthermia Cancer Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Hyperthermia Cancer Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Hyperthermia Cancer Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Hyperthermia Cancer Treatment Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Hyperthermia Cancer Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Hyperthermia Cancer Treatment Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Andromedic S.r.l.
    • 12.2.2. Oncotherm Kft
    • 12.2.3. YAMAMOTO VINITA CO., LTD
    • 12.2.4. Alba Hyperthermia System
    • 12.2.5. Sensius, MagForce AG
    • 12.2.6. Celsius42 GmbH
    • 12.2.7. Pyrexar Medical
    • 12.2.8. Nanoprobes
    • 12.2.9. Novavida
    • 12.2.10. Hydrosun GmbH
    • 12.2.11. Chongqing Haifu Medical Technology Co., Ltd.
    • 12.2.12. RanD
    • 12.2.13. Gamida
    • 12.2.14. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us